Intelligence Platform

Patents

Browse 14,889 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 6500433

Polypeptide fragments capable of competition with Streptococcus mutans antigen I/II

The Council of Governors of the United Medical & Dental School of Guy's and St. Thomas's Hospitals · Granted Tue Dec 31 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6500108

Radiation delivery system and method

The Regents of the University of California · Granted Tue Dec 31 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6498238

Glycopeptide antibacterial compounds, compositions containing same and methods of using sa

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Dec 24 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6498189

Method for induction of L-selectin shedding

The Regents of the University of New Mexico · Granted Tue Dec 24 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6498148

Immunization-free methods for treating antigen-stimulated inflammation in a mammalian host

The Regents of the University of California · Granted Tue Dec 24 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6497902

Ionically crosslinked hydrogels with adjustable gelation time

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Dec 24 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6495736

Compositions and methods for increasing bone mineralization

Darwin Discovery Limited · Granted Tue Dec 17 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6495721

Sertraline hydrochloride Form II and methods for the preparation thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 17 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6495582

Isoxazole compositions useful as inhibitors of ERK

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 17 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6495145

LktA deletion mutant of P. haemolytica

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Dec 17 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6495072

Method for making basis for a dental restoration

Cicero Dental Systems, B.V. · Granted Tue Dec 17 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6492104

EIA test using nondenatured HIV antigen for early detection of HIV infection

The Board of Regents of the University of Texas System · Granted Tue Dec 10 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6491906

CXC chemokines as regulators of angiogenesis

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Dec 10 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6491908

Selective elimination of T cells that recognize specific preselected targets

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 10 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6489308

Inhibitors of serine protease activity, methods and compositions for treatment of nitric-o

The Regents of the University of Technology Office of Technology Transfer · Granted Tue Dec 03 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6489299

Methods for treatment of multiple sclerosis using peptide analogues at position 91 of huma

Neurocrine Biosciences, Inc. · Granted Tue Dec 03 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6489163

Ribozyme mediated inactivation of the androgen receptor

The Board of Regents of the University of Texas System · Granted Tue Dec 03 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6489144

Methods for enhancing the production of interferon in cell culture

The Regents of the University of California · Granted Tue Dec 03 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6489315

Cyclic compounds, their production and use

Takeda Chemical Industries Ltd. · Granted Tue Dec 03 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6485746

Controlled-release sedative-hypnotic compositions and methods related thereto

Neurocrine Biosciences, Inc. · Granted Tue Nov 26 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6486166

Suppression of cyclin kinase 2 activity for prevention and treatment of DNA viral infectio

The Board of Regents of the University of Texas · Granted Tue Nov 26 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6482864

Sustained-release preparation of physiologically active polypeptide and production thereof

Takeda Chemical Industries Ltd. · Granted Tue Nov 19 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6482803

Modification of mutated P53 gene in tumors by retroviral delivery of ribozyme A

The Board of Regents of the University of Texas System · Granted Tue Nov 19 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6482417

Stable pharmaceutical formulation comprising torsemide modification II

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 19 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired